Market›Health Care›Health Care Providers & Services›Health Care Facilities
BIOCORRX INC

BICX

$0.43Apr 28, 2021 – Apr 27, 2026
Health CareHealth Care Providers & ServicesHealth Care Facilities$11M
MVM
+$0.0M

Every news event mapped to its market reaction — 42 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2021-09-02+62.1%legalSEC EDGARBICX 8-K: 8.01 and (SEC Filing)
2025-03-11+44.3%legalSEC EDGARBICX 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2024-08-16-34.2%earningsSeeking AlphaBioCorRx GAAP EPS of -$0.13, revenue of $4.04K
2025-08-01+25.9%legalSEC EDGARBICX 8-K: 1.01, 3.02 (SEC Filing)
2024-04-03+22.6%newsSeeking AlphaBioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia
2024-04-03+22.6%legalSEC EDGARBICX 8-K: 5.02 (SEC Filing)
2022-05-07+20.5%newsSeeking AlphaBioCorRx (BICX) Investor Presentation - Slideshow
2023-07-17+17.7%newsStock TitanARBH Stock Price, News & Analysis - Stock Titan
2023-12-15-10.0%legalSEC EDGARBICX 8-K: 1.01, 3.02 (SEC Filing)
2024-01-05-8.9%legalSEC EDGARBICX 8-K: 5.02 and (SEC Filing)
2023-01-23+8.0%legalSEC EDGARBICX 8-K: 5.02 and (SEC Filing)
2022-04-19+7.8%legalTMX NewsfileBioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast - TMX Newsfile
2022-01-19+7.1%legalSEC EDGARBICX 8-K: 1.01 and (SEC Filing)
2022-06-10+7.0%legalSEC EDGARBICX 8-K: 8.01 (SEC Filing)
2021-05-10+6.4%legalSeeking AlphaBioCorRx gets FDA clearance for BICX104 Opioid Use Disorder treatment trials
2022-03-16-6.3%newsSeeking AlphaBioCorRx gets review board nod to begin phase 1 trial of BICX104 for opioid use disorder
2023-11-02-4.7%legalSEC EDGARBICX 8-K: 5.02 (SEC Filing)
2021-05-18+4.5%earningsSeeking AlphaBioCorRx posts wider Q1 loss, raises going concern doubts
2021-05-18+4.5%earningsSeeking AlphaBioCorRx reports Q1 results
2021-11-16+3.4%earningsSeeking AlphaBioCorRx reports Q3 results
2022-04-28+2.9%legalSEC EDGARBICX 8-K: 5.02 and (SEC Filing)
2023-05-16+2.9%earningsSeeking AlphaBioCorRx GAAP EPS of -$0.13
2025-04-24-2.8%newsStock TitanGBCS Stock Price, News & Analysis | Selectis Health - Stock Titan
2025-04-24-2.8%newsStock TitanKONEF Stock Price, News & Analysis - Stock Titan
2023-11-16-2.7%legalSEC EDGARBICX 8-K: 1.01, 3.02 (SEC Filing)
2023-04-11-2.4%legalSEC EDGARBICX 8-K: 1.01 and (SEC Filing)
2022-05-12-2.3%legalSEC EDGARBICX 8-K: 1.01 and (SEC Filing)
2022-11-22-2.0%newsSeeking AlphaBioCorRx to explore potential spin-off of BioCorRx Pharma
2026-03-11+1.9%newsNewMediaWireBioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone Implant Technology
2022-05-17+1.4%earningsSeeking AlphaBioCorRx GAAP EPS of -$0.14, revenue of $0.02M
2022-04-27-1.2%newsSeeking AlphaBioCorRx starts recruiting in trial of biodegradable naltrexone pellet BICX104 for opioid disorder
2025-04-25-0.8%newsStock TitanBICX Stock Price, News & Analysis - Stock Titan
2025-04-25-0.8%newsStock TitanCDIX Stock Price, News & Analysis - Stock Titan
2025-04-25-0.8%newsStock TitanVLXC Stock Price, News & Analysis - Stock Titan
2026-04-02-0.6%legalSEC EDGARBICX 8-K: 1.01, 3.02 (SEC Filing)
2026-04-02-0.6%M&ATipRanksBioCorRx Reorganizes Subsidiary Through Equity Exchange Deal - TipRanks
2022-08-16-0.4%earningsSeeking AlphaBioCorRx GAAP EPS of -$0.19, revenue of $16.01M
2021-11-22+0.4%M&ASeeking AlphaBioCorRx acquires Intellectual Property for drug delivery
2022-07-06+0.2%expansionTMX NewsfileBioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast - TMX Newsfile
2023-04-03+0.2%earningsSeeking AlphaBioCorRx FY22 revenue grows 343% Y/Y
2023-04-05-0.1%legalSEC EDGARBICX 8-K: 1.01, 3.02 (SEC Filing)
2022-11-15-0.1%newsSeeking AlphaBioCorRx reports results
tickerdossier.comtickerdossier.substack.com